FDA PMA
FDA Class 3
Approved
🇺🇸 United States
System, Photopheresis, Extracorporeal
PMA: P860003
·
Supplement: S090
·
Decision Jul 21, 2017
Classifications
1
FEI Numbers
11
Registration Numbers
11
Basic Information
- Device Name
- System, Photopheresis, Extracorporeal
- Trade Name
- Therakos CELLEX Photopheresis System
- PMA Number
- P860003
- Supplement Number
- S090
- Device Class
- FDA Class 3
- Product Code
- LNR
- Generic Name
- System, photopheresis, extracorporeal
- Medical Specialty
- Unknown
- Advisory Committee
- Gastroenterology, Urology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- July 21, 2017
- Date Received
- May 22, 2017
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for a design change to replace the 24 V power supply in the device.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LNR | System, Photopheresis, Extracorporeal | FDA class 3 | Unknown |